.Bicara Therapies and also Zenas Biopharma have actually delivered clean inspiration to the IPO mark...
.Genentech will certainly close its own cancer immunology investigation department, and also unit he...
.Kezar Lifestyle Sciences is actually dropping its dim phase 1 solid growth medicine as the biotech ...
.In spite of izokibep keeping its newfound winning streak in the clinic, Acelyrin is actually no mor...
.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing medicati...
.Ovid Therapeutics already uncovered last month that it was trimming back its own headcount as the f...
.Eli Lilly has opened up a $700 thousand R&D facility in the Boston Seaport, improving its RNA an...
.Only 5 months after safeguarding a $one hundred million IPO, Vast Bio is already laying off some em...
.The first phases of oncology R&D may not be short of intriguing new modalities, and Halda Therap...
.Psychopharmacology has actually drawn three write-ups about midstage medical trial data analyzing L...